InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Lubniewski John L, Chairman & CEO. Insider active across 1 company, notably HTG Molecular Diagnostics, INC. Aggregated, 14 disclosures have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
1,000 shares@ US$0.4252.6% of flowCommon StockSEC:0001209191-22-061008:0
61 shares@ US$1.030.4% of flowCommon StockSEC:0001209191-22-040338:0
1,000 shares@ US$0.4763.0% of flowCommon StockSEC:0001209191-22-036957:0
62 shares@ US$1.390.5% of flowCommon StockSEC:0001209191-22-022364:0
62 shares@ US$5.421.9% of flowCommon StockSEC:0001209191-22-000830
62 shares@ US$5.422.0% of flowCommon StockSEC:0001209191-22-000830:0
1,000 shares@ US$3.561520.3% of flowCommon StockSEC:0001209191-21-069771
1,000 shares@ US$3.561520.8% of flowCommon StockSEC:0001209191-21-069771:0
62 shares@ US$5.712.0% of flowCommon StockSEC:0001209191-21-059000
62 shares@ US$5.712.0% of flowCommon StockSEC:0001209191-21-059000:0
62 shares@ US$5.812.0% of flowCommon StockSEC:0001209191-21-045179:0
62 shares@ US$5.812.0% of flowCommon StockSEC:0001209191-21-045179
1,000 shares@ US$3.918520.7% of flowCommon StockSEC:0001209191-21-040442
1,000 shares@ US$3.918521.3% of flowCommon StockSEC:0001209191-21-040442:0
14 of 14 declarations
About Lubniewski John L
John L. Lubniewski is the President and CEO of HTG MOLECULAR DIAGNOSTICS, INC. He leads the company by implementing strategies aimed at improving performance and fostering innovation in the molecular diagnostics sector.
